Search research articles
Contact Us
Filters
Showing results (61-70 of 89) with videos related to
Page
of 9
Sort By:
Medical Oncology (Northwood, London, England)
|
October 25, 2017
Significance of a frozen section analysis of the ureteral margin in bladder cancer patients treated with radical cystectomy and neoadjuvant chemotherapy
Kyohei Hakozaki, Eiji Kikuchi, Keishiro Fukumoto, et al.
IJU Case Reports
|
August 4, 2020
A case in which bladder cancer invaded the ureteral orifice and was resected via photodynamic diagnosis-assisted transurethral resection involving orally administered 5-aminolevulinic acid
Keitaro Watanabe, Suguru Shirotake, Yuta Umezawa, et al.
BJUI Compass
|
February 19, 2024
New risk stratification for adjuvant nivolumab for high-risk muscle-invasive urothelial carcinoma
Takafumi Saito, Kent Kanao, Kazuhiro Matsumoto, et al.
International Journal of Clinical Oncology
|
July 24, 2024
Prognostic significance of inflammatory markers in patients with advanced renal cell carcinoma receiving nivolumab plus ipilimumab
Takayuki Nakayama, Hideki Takeshita, Makoto Kagawa, et al.
International Journal of Clinical Oncology
|
June 8, 2021
On-treatment C-reactive protein control could predict response to subsequent anti-PD-1 treatment in metastatic renal cell carcinoma
Kimiharu Takamatsu, Ryuichi Mizuno, Yuto Baba, et al.
Anticancer Research
|
April 30, 2022
Impact of Cytoreductive Nephrectomy Following Nivolumab Plus Ipilimumab Therapy for Patients With Advanced Renal Cell Carcinoma
Suguru Shirotake, Y U Miyama, Yasutaka Baba, et al.
Japanese Journal of Clinical Oncology
|
May 8, 2019
Sub-classification of patients with intermediate-risk metastatic renal cell carcinoma treated with targeted therapy
Go Kaneko, Suguru Shirotake, Koshiro Nishimoto, et al.
Japanese Journal of Clinical Oncology
|
March 11, 2016
Patient age was an independent predictor of cancer-specific survival in male patients with upper tract urothelial carcinoma treated by radical nephroureterectomy
Hiroaki Kobayashi, Eiji Kikuchi, Nobuyuki Tanaka, et al.
International Journal of Clinical Oncology
|
September 2, 2023
Association between immune-related adverse events and survival in patients with renal cell carcinoma treated with nivolumab plus ipilimumab: immortal time bias-corrected analysis
Satoshi Washino, Suguru Shirotake, Hideki Takeshita, et al.
Japanese Journal of Clinical Oncology
|
September 7, 2020
Significance of prophylactic urethrectomy at the time of radical cystectomy for bladder cancer
Kyohei Hakozaki, Eiji Kikuchi, Koichiro Ogihara, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 89) with videos related to
Sort By:
Page
of 9
Medical Oncology (Northwood, London, England)
|
October 25, 2017
Significance of a frozen section analysis of the ureteral margin in bladder cancer patients treated with radical cystectomy and neoadjuvant chemotherapy
Kyohei Hakozaki, Eiji Kikuchi, Keishiro Fukumoto, et al.
IJU Case Reports
|
August 4, 2020
A case in which bladder cancer invaded the ureteral orifice and was resected via photodynamic diagnosis-assisted transurethral resection involving orally administered 5-aminolevulinic acid
Keitaro Watanabe, Suguru Shirotake, Yuta Umezawa, et al.
BJUI Compass
|
February 19, 2024
New risk stratification for adjuvant nivolumab for high-risk muscle-invasive urothelial carcinoma
Takafumi Saito, Kent Kanao, Kazuhiro Matsumoto, et al.
International Journal of Clinical Oncology
|
July 24, 2024
Prognostic significance of inflammatory markers in patients with advanced renal cell carcinoma receiving nivolumab plus ipilimumab
Takayuki Nakayama, Hideki Takeshita, Makoto Kagawa, et al.
International Journal of Clinical Oncology
|
June 8, 2021
On-treatment C-reactive protein control could predict response to subsequent anti-PD-1 treatment in metastatic renal cell carcinoma
Kimiharu Takamatsu, Ryuichi Mizuno, Yuto Baba, et al.
Anticancer Research
|
April 30, 2022
Impact of Cytoreductive Nephrectomy Following Nivolumab Plus Ipilimumab Therapy for Patients With Advanced Renal Cell Carcinoma
Suguru Shirotake, Y U Miyama, Yasutaka Baba, et al.
Japanese Journal of Clinical Oncology
|
May 8, 2019
Sub-classification of patients with intermediate-risk metastatic renal cell carcinoma treated with targeted therapy
Go Kaneko, Suguru Shirotake, Koshiro Nishimoto, et al.
Japanese Journal of Clinical Oncology
|
March 11, 2016
Patient age was an independent predictor of cancer-specific survival in male patients with upper tract urothelial carcinoma treated by radical nephroureterectomy
Hiroaki Kobayashi, Eiji Kikuchi, Nobuyuki Tanaka, et al.
International Journal of Clinical Oncology
|
September 2, 2023
Association between immune-related adverse events and survival in patients with renal cell carcinoma treated with nivolumab plus ipilimumab: immortal time bias-corrected analysis
Satoshi Washino, Suguru Shirotake, Hideki Takeshita, et al.
Japanese Journal of Clinical Oncology
|
September 7, 2020
Significance of prophylactic urethrectomy at the time of radical cystectomy for bladder cancer
Kyohei Hakozaki, Eiji Kikuchi, Koichiro Ogihara, et al.
Page
of 9